Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9UHN1
UPID:
DPOG2_HUMAN
Alternative names:
DNA polymerase gamma accessory 55 kDa subunit; Mitochondrial DNA polymerase accessory subunit; MtPolB; PolG-beta
Alternative UPACC:
Q9UHN1; O00419; Q0IJ81; Q96GW2; Q9UK35; Q9UK94
Background:
DNA polymerase subunit gamma-2, mitochondrial, also known as DNA polymerase gamma accessory 55 kDa subunit, plays a crucial role in mitochondrial DNA replication and repair. It enhances the processivity of DNA synthesis by binding to single-stranded DNA. This protein is pivotal for mitochondrial function and cellular energy production.
Therapeutic significance:
Mutations in DNA polymerase subunit gamma-2 are linked to several mitochondrial disorders, including Progressive external ophthalmoplegia and Mitochondrial DNA depletion syndromes. Understanding its function could lead to novel therapeutic strategies for these debilitating conditions.